前列腺MRI中PI-RADS第2版评分1分的阴性预测值及与假阴性MRI研究相关的因素
回顾性纳入542例PI-RADS 1分前列腺MRI患者,其中150例后续行前列腺活检,19例(13%)为Gleason评分≥3+4前列腺癌,阴性预测值为87%。外周带T2低信号和前列腺特异性抗原水平与假阴性评估相关(OR分别为4.9和1.1),PSA cutoff 3.97 ng/mL对应敏感度89%、特异度21%。
要点
- PI-RADS 1分前列腺MRI的阴性预测值为87%,但仍有13%患者活检为Gleason≥3+4前列腺癌。
- 外周带T2低信号(OR 4.9,95%CI 1.6-14.9,p=0.006)和PSA水平(OR 1.1,95%CI 1.0-1.2,p=0.03)与假阴性相关。
- PSA cutoff 3.97 ng/mL对应敏感度89%、特异度21%;外周带T2低信号观察者间一致性中等(κ=0.75)。
核心结论
- 即使在高临床怀疑前列腺癌而后续行活检的选择性患者中,PI-RADS 1分前列腺MRI研究仍具有高阴性预测值。
- 外周带T2低信号和PSA水平升高与假阴性MRI研究显著相关。
研究设计与样本
- 回顾性识别2016年1月至2019年7月间542例连续PI-RADS 1分前列腺MRI患者。
- 最终纳入150例(中位年龄63岁,四分位距56-70岁)在MRI后1年内或更晚(如活检阴性)行系统性前列腺活检的患者。
- 两位盲法放射科医师评估轴位T2加权、DWI和ADC序列质量,测量膀胱、前列腺和直肠气体体积,判断外周带是否明显强化及T2加权像上外周带低信号是否≥50%。
- 参考标准为前列腺活检病理;采用单变量和多变量逻辑回归模型分析。
关键影像表现/征象
- 外周带T2低信号与假阴性PI-RADS 1评估相关(OR 4.9,95%CI 1.6-14.9,p=0.006)。
- 前列腺特异性抗原水平与假阴性PI-RADS 1评估相关(OR 1.1,95%CI 1.0-1.2,p=0.03)。
- 外周带T2低信号的观察者间一致性为中等(κ=0.75)。
诊断标准与关键数值
- PI-RADSv2评分1分(PI-RADS 1)定义为前列腺MRI研究。
- 阴性预测值87%(19/150例活检为Gleason评分3+4或更高前列腺癌)。
- PSA cutoff 3.97 ng/mL对应敏感度89%、特异度21%。
临床应用与阅片要点
- PI-RADS 1分前列腺MRI具有高阴性预测值,但需注意外周带T2低信号和PSA水平升高的患者仍可能出现假阴性。
- 外周带T2低信号观察者间一致性中等(κ=0.75),判读时需关注该征象。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE. The purpose of this study was to calculate the negative predictive value of a prostate MRI study with a Prostate Imaging Reporting and Data System version 2 (PI-RADSv2) score of 1 (hereafter referred to as a PI-RADS 1 MRI study) and to explore the patient characteristics and MRI-based factors associated with an MRI study with false-negative results. MATERIALS AND METHODS. A total of 542 consecutive patients with a PI-RADS 1 MRI study obtained between January 2016 and July 2019 were retrospectively identified. Patient charts were examined to identify those patients who subsequently underwent systematic prostate biopsy within 1 year of undergoing MRI or at any later date if the biopsy was negative. Patient characteristics and MRI-specific factors were recorded. Two blinded radiologists evaluated the quality of the axial T2-weighted, DWI, and apparent diffusion coefficient sequences; measured the volume of the bladder, the prostate gland, and rectal gas; and determined whether the peripheral zone was avidly enhancing and whether low signal intensity was seen in 50% or more of the peripheral zone on T2-weighted images. Interobserver agreement was tested. Univariable and multivariable logistic regression models were built. RESULTS. A total of 150 patients (median age, 63 years; interquartile range, 56-70 years) were included. Of these patients, 19 (13%) had prostate cancer with a Gleason score of 3 + 4 or greater, yielding a negative predictive value of 87%. Both low T2 signal intensity in the peripheral zone and the prostate-specific antigen level were associated with a false-negative PI-RADS 1 assessment (odds ratio, 4.9 [95% CI, 1.6-14.9; p = 0.006] and 1.1 [95% CI, 1.0-1.2; p = 0.03], respectively). A cutoff prostate-specific antigen level of 3.97 ng/mL resulted in sensitivity and specificity of 89% and 21%, respectively. There was moderate interobserver agreement for low T2 signal intensity in the peripheral zone (κ coefficient = 0.75). CONCLUSION. Even among select patients who undergo subsequent biopsy because of a high clinical suspicion of prostate cancer, a PI-RADS 1 prostate MRI study has a high negative predictive value. A T2-hypointense peripheral zone and an elevated prostate-specific antigen level are significantly associated with a false-negative MRI study.
引用
- Ma HY, Ahmed FS, Luk L, et al. The Negative Predictive Value of a PI-RADS Version 2 Score of 1 on Prostate MRI and the Factors Associated With a False-Negative MRI Study. AJR Am J Roentgenol. 2020. PMID: 32755155. doi:10.2214/AJR.20.22784
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。